Original Research
Published on 14 Jun 2021
Shifted Dynamics of Glucose Metabolism in the Hippocampus During Aging
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.700306
- 4,376 views
- 8 citations
Type at least 3 characters
1,963 articles
Articles
Original Research
Published on 11 Jun 2021
Analysis of Age-Dependent Alterations in Excitability Properties of CA1 Pyramidal Neurons in an APPPS1 Model of Alzheimer’s Disease
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.668948
- 4,764 views
- 19 citations
Original Research
Published on 07 Jun 2021
The Significance of EEG Alpha Oscillation Spectral Power and Beta Oscillation Phase Synchronization for Diagnosing Probable Alzheimer Disease
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.631587
- 6,023 views
- 18 citations
Original Research
Published on 04 Jun 2021
Blood Pressure Level Is Associated With Changes in Plasma Aβ1 –40 and Aβ1–42 Levels: A Cross-sectional Study Conducted in the Suburbs of Xi’an, China
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.650679
- 2,905 views
- 7 citations
Original Research
Published on 03 Jun 2021
Amyloid β and Amyloid Precursor Protein Synergistically Suppress Large-Conductance Calcium-Activated Potassium Channel in Cortical Neurons
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.660319
- 3,772 views
- 12 citations
Review
Published on 28 May 2021
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.650047
- 21,860 views
- 87 citations
Original Research
Published on 28 May 2021
Similar Genetic Architecture of Alzheimer’s Disease and Differential APOE Effect Between Sexes
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.674318
- 5,045 views
- 12 citations
Original Research
Published on 28 May 2021
Better Identification of Cognitive Decline With Interleukin-2 Than With Amyloid and Tau Protein Biomarkers in Amnestic Mild Cognitive Impairment
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.670115
- 4,233 views
- 11 citations
Original Research
Published on 28 May 2021
The Role of Plasma Neurofilament Light Protein for Assessing Cognitive Impairment in Patients With End-Stage Renal Disease
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.657794
- 4,231 views
- 12 citations
Systematic Review
Published on 26 May 2021
Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.665114
- 10,808 views
- 43 citations
Original Research
Published on 20 May 2021
Predictive Value of Cerebrospinal Fluid Biomarkers for Tap Test Responsiveness in Patients With Suspected Idiopathic Normal Pressure Hydrocephalus
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.665878
- 2,904 views
- 4 citations
Original Research
Published on 19 May 2021
Language Impairment in Alzheimer’s Disease—Robust and Explainable Evidence for AD-Related Deterioration of Spontaneous Speech Through Multilingual Machine Learning
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.642033
- 14,161 views
- 33 citations
Original Research
Published on 17 May 2021
Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.658605
- 10,244 views
- 12 citations
Original Research
Published on 13 May 2021
Increased Plasma Level of 24S-Hydroxycholesterol and Polymorphism of CYP46A1 SNP (rs754203) Are Associated With Mild Cognitive Impairment in Patients With Type 2 Diabetes
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.619916
- 3,752 views
- 13 citations
Original Research
Published on 11 May 2021
Dichlorodiphenyltrichloroethane Impairs Amyloid Beta Clearance by Decreasing Liver X Receptor α Expression
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.634948
- 3,348 views
- 5 citations
Brief Research Report
Published on 10 May 2021
Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population
in Alzheimer's Disease and Related Dementias
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.659898
- 4,989 views
- 9 citations